The global market size was valued at US$ 45.67 billion in 2024 and is projected to reach US$ 78.92 billion by 2030, at a CAGR of 9.5% during the forecast period 2024-2030.
The United States market size was valued at US$ 15.34 billion in 2024 and is projected to reach US$ 25.67 billion by 2030, at a CAGR of 8.9% during the forecast period 2024-2030.
Medications treating various neurological conditions.
Patient treatments reached 450 million in 2023. Novel therapies grow at 11.2% annually. Market saw 45% increase in precision medicine. Approvals obtained in 85 countries. Future projects worth US$ 12.45 billion by 2026. North America leads with 45% market share.
Report Overview
A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
This report provides a deep insight into the global Neurologic Disorders Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurologic Disorders Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurologic Disorders Therapeutics market in any manner.
Global Neurologic Disorders Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen Inc.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
Market Segmentation (by Type)
Central Nervous System (CNS)
Peripheral Nervous System (PNS)
Market Segmentation (by Application)
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurologic Disorders Therapeutics Market
Overview of the regional outlook of the Neurologic Disorders Therapeutics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurologic Disorders Therapeutics
1.2 Key Market Segments
1.2.1 Neurologic Disorders Therapeutics Segment by Type
1.2.2 Neurologic Disorders Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurologic Disorders Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Neurologic Disorders Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurologic Disorders Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurologic Disorders Therapeutics Market Competitive Landscape
3.1 Global Neurologic Disorders Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurologic Disorders Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurologic Disorders Therapeutics Sales Sites, Area Served, Product Type
3.6 Neurologic Disorders Therapeutics Market Competitive Situation and Trends
3.6.1 Neurologic Disorders Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurologic Disorders Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurologic Disorders Therapeutics Industry Chain Analysis
4.1 Neurologic Disorders Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurologic Disorders Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurologic Disorders Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurologic Disorders Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Neurologic Disorders Therapeutics Price by Type (2019-2024)
7 Neurologic Disorders Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurologic Disorders Therapeutics Market Sales by Application (2019-2024)
7.3 Global Neurologic Disorders Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Neurologic Disorders Therapeutics Sales Growth Rate by Application (2019-2024)
8 Neurologic Disorders Therapeutics Market Segmentation by Region
8.1 Global Neurologic Disorders Therapeutics Sales by Region
8.1.1 Global Neurologic Disorders Therapeutics Sales by Region
8.1.2 Global Neurologic Disorders Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Neurologic Disorders Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurologic Disorders Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurologic Disorders Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurologic Disorders Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurologic Disorders Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biogen Inc.
9.1.1 Biogen Inc. Neurologic Disorders Therapeutics Basic Information
9.1.2 Biogen Inc. Neurologic Disorders Therapeutics Product Overview
9.1.3 Biogen Inc. Neurologic Disorders Therapeutics Product Market Performance
9.1.4 Biogen Inc. Business Overview
9.1.5 Biogen Inc. Neurologic Disorders Therapeutics SWOT Analysis
9.1.6 Biogen Inc. Recent Developments
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Basic Information
9.2.2 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Overview
9.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd. Business Overview
9.2.5 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.3 Johnson and Johnson Services Inc.
9.3.1 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Basic Information
9.3.2 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Product Overview
9.3.3 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Product Market Performance
9.3.4 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics SWOT Analysis
9.3.5 Johnson and Johnson Services Inc. Business Overview
9.3.6 Johnson and Johnson Services Inc. Recent Developments
9.4 Novartis AG
9.4.1 Novartis AG Neurologic Disorders Therapeutics Basic Information
9.4.2 Novartis AG Neurologic Disorders Therapeutics Product Overview
9.4.3 Novartis AG Neurologic Disorders Therapeutics Product Market Performance
9.4.4 Novartis AG Business Overview
9.4.5 Novartis AG Recent Developments
9.5 Pfizer Inc.
9.5.1 Pfizer Inc. Neurologic Disorders Therapeutics Basic Information
9.5.2 Pfizer Inc. Neurologic Disorders Therapeutics Product Overview
9.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Product Market Performance
9.5.4 Pfizer Inc. Business Overview
9.5.5 Pfizer Inc. Recent Developments
10 Neurologic Disorders Therapeutics Market Forecast by Region
10.1 Global Neurologic Disorders Therapeutics Market Size Forecast
10.2 Global Neurologic Disorders Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurologic Disorders Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Neurologic Disorders Therapeutics Market Size Forecast by Region
10.2.4 South America Neurologic Disorders Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurologic Disorders Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neurologic Disorders Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurologic Disorders Therapeutics by Type (2025-2030)
11.1.2 Global Neurologic Disorders Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurologic Disorders Therapeutics by Type (2025-2030)
11.2 Global Neurologic Disorders Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Neurologic Disorders Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Neurologic Disorders Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurologic Disorders Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Neurologic Disorders Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Neurologic Disorders Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neurologic Disorders Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neurologic Disorders Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorders Therapeutics as of 2022)
Table 10. Global Market Neurologic Disorders Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neurologic Disorders Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Neurologic Disorders Therapeutics Product Type
Table 13. Global Neurologic Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurologic Disorders Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurologic Disorders Therapeutics Market Challenges
Table 22. Global Neurologic Disorders Therapeutics Sales by Type (K Units)
Table 23. Global Neurologic Disorders Therapeutics Market Size by Type (M USD)
Table 24. Global Neurologic Disorders Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Neurologic Disorders Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Neurologic Disorders Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Neurologic Disorders Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Neurologic Disorders Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Neurologic Disorders Therapeutics Sales (K Units) by Application
Table 30. Global Neurologic Disorders Therapeutics Market Size by Application
Table 31. Global Neurologic Disorders Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Neurologic Disorders Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Neurologic Disorders Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Neurologic Disorders Therapeutics Market Share by Application (2019-2024)
Table 35. Global Neurologic Disorders Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Neurologic Disorders Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Neurologic Disorders Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Neurologic Disorders Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Neurologic Disorders Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Neurologic Disorders Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Neurologic Disorders Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Neurologic Disorders Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Biogen Inc. Neurologic Disorders Therapeutics Basic Information
Table 44. Biogen Inc. Neurologic Disorders Therapeutics Product Overview
Table 45. Biogen Inc. Neurologic Disorders Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biogen Inc. Business Overview
Table 47. Biogen Inc. Neurologic Disorders Therapeutics SWOT Analysis
Table 48. Biogen Inc. Recent Developments
Table 49. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Basic Information
Table 50. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Overview
Table 51. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. F. Hoffmann-La Roche Ltd. Business Overview
Table 53. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics SWOT Analysis
Table 54. F. Hoffmann-La Roche Ltd. Recent Developments
Table 55. Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Basic Information
Table 56. Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Product Overview
Table 57. Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics SWOT Analysis
Table 59. Johnson and Johnson Services Inc. Business Overview
Table 60. Johnson and Johnson Services Inc. Recent Developments
Table 61. Novartis AG Neurologic Disorders Therapeutics Basic Information
Table 62. Novartis AG Neurologic Disorders Therapeutics Product Overview
Table 63. Novartis AG Neurologic Disorders Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Recent Developments
Table 66. Pfizer Inc. Neurologic Disorders Therapeutics Basic Information
Table 67. Pfizer Inc. Neurologic Disorders Therapeutics Product Overview
Table 68. Pfizer Inc. Neurologic Disorders Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pfizer Inc. Business Overview
Table 70. Pfizer Inc. Recent Developments
Table 71. Global Neurologic Disorders Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 72. Global Neurologic Disorders Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Neurologic Disorders Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 74. North America Neurologic Disorders Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Neurologic Disorders Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Neurologic Disorders Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Neurologic Disorders Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 78. Asia Pacific Neurologic Disorders Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Neurologic Disorders Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 80. South America Neurologic Disorders Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Neurologic Disorders Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Neurologic Disorders Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Neurologic Disorders Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 84. Global Neurologic Disorders Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Neurologic Disorders Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 86. Global Neurologic Disorders Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 87. Global Neurologic Disorders Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Neurologic Disorders Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurologic Disorders Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Neurologic Disorders Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Neurologic Disorders Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurologic Disorders Therapeutics Market Size by Country (M USD)
Figure 11. Neurologic Disorders Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Neurologic Disorders Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurologic Disorders Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurologic Disorders Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurologic Disorders Therapeutics Market Share by Type
Figure 18. Sales Market Share of Neurologic Disorders Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Neurologic Disorders Therapeutics by Type in 2023
Figure 20. Market Size Share of Neurologic Disorders Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Neurologic Disorders Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurologic Disorders Therapeutics Market Share by Application
Figure 24. Global Neurologic Disorders Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Neurologic Disorders Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Neurologic Disorders Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Neurologic Disorders Therapeutics Market Share by Application in 2023
Figure 28. Global Neurologic Disorders Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neurologic Disorders Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Neurologic Disorders Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Neurologic Disorders Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Neurologic Disorders Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Neurologic Disorders Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Neurologic Disorders Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Neurologic Disorders Therapeutics Sales Market Share by Region in 2023
Figure 44. China Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Neurologic Disorders Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Neurologic Disorders Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Neurologic Disorders Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Neurologic Disorders Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Neurologic Disorders Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Neurologic Disorders Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Neurologic Disorders Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neurologic Disorders Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neurologic Disorders Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Neurologic Disorders Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Neurologic Disorders Therapeutics Market Share Forecast by Application (2025-2030)
